Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06416059 · ClinicalTrials.gov registry record · NA

A Mobile Intervention for Black Individuals Who Engage in Hazardous Drinking

A NA study of Anxiety and Alcohol Abuse, sponsored by University of Houston.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06416059 is a NA study of Anxiety and Alcohol Abuse that is actively recruiting participants, run by University of Houston. The registered enrollment target is 50 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06416059, a NA study of Anxiety and Alcohol Abuse, is actively recruiting participants, sponsored by University of Houston.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to develop and examine a culturally adapted, mobile health application for the Android and iOS platform. The application uses a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intention regarding anxiety-related alcohol use among Black hazardous drinkers with clinical anxiety.

Conditions Studied

Interventions

  • BEHAVIORAL Mobile Application

Study Locations (1)

Texas

  • RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity - Houston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-05-15
Est. Completion 2024-08-31
Phase NA

Sponsor

University of Houston

64 total trials

What the Registry Record Tells You About NCT06416059

The ClinicalTrials.gov registry entry for NCT06416059 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (89% lower). The listed sponsor is University of Houston, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Mobile Application is the first listed.

NCT06416059 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06416059 about?

NCT06416059 is a clinical study titled "A Mobile Intervention for Black Individuals Who Engage in Hazardous Drinking". The purpose of this study is to develop and examine a culturally adapted, mobile health application for the Android and iOS platform. The application uses a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation an...

What is the current status of trial NCT06416059?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-05-15. Estimated completion is 2024-08-31.

What conditions does trial NCT06416059 study?

This clinical trial studies the following conditions: Anxiety, Alcohol Abuse.

What interventions are being tested in trial NCT06416059?

The interventions under investigation include: Mobile Application (BEHAVIORAL).

Who is sponsoring clinical trial NCT06416059?

This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06416059 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.